Agnirva Space Premier League - Expedition #31378: Combating Dizziness After Spaceflight: Testing Midodrine Over the Long Haul

One of the lesser-known but serious challenges astronauts face upon returning to Earth is orthostatic hypotension — a condition where blood pressure drops significantly when standing up, causing dizziness, fainting, or even blackouts. After spending months in microgravity, the human body adapts to the weightless environment, and one of the consequences is a reduced ability to regulate blood pressure when gravity returns. NASA’s long-duration investigation into using Midodrine as a pharmaceutical countermeasure is a critical effort to solve this problem.

This research, conducted during Expeditions 16 and 17 on the International Space Station (ISS), sought to determine whether Midodrine — a vasoconstrictor commonly used to treat chronic orthostatic hypotension on Earth — could also help astronauts readjust their cardiovascular systems after prolonged periods in space. The idea was simple but powerful: by constricting blood vessels, Midodrine could prevent the excessive pooling of blood in the legs when astronauts stood up, thereby maintaining adequate cerebral perfusion and preventing fainting.

Researchers administered the drug to astronauts before their return to Earth and monitored cardiovascular responses through a series of diagnostic tests. These tests included tilt-table evaluations and continuous blood pressure monitoring both in orbit and after landing. The data collected contributed not only to validating the efficacy of Midodrine in space medicine but also deepened our understanding of how microgravity affects the human autonomic nervous system.

While the results were promising, this experiment also highlighted the need for individualized treatment plans, as not all astronauts responded equally to the medication. Variables such as age, mission duration, and individual physiological differences all played a role. Additionally, the study served as a valuable stepping stone for future pharmaceutical strategies to keep astronauts safe during longer missions — including potential trips to Mars.

The Midodrine study underscores the importance of space-based biomedical research and its potential to influence treatment paradigms on Earth, especially for populations prone to fainting and low blood pressure due to illness or aging.

Join the Agnirva Space Internship Program

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.